James G. Bender Insider Trading
Get free email notifications about insider trading for James G. Bender.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James G. Bender. James G. Bender is a VP Product Development & Mfg. in ImmunoCellular Therapeutics, Ltd. ($IMUC) and a VP, Product Development & Mfg. in ImmunoCellular Therapeutics, Ltd. ($IMUC) and a Vice President - Manufacturing in Lion Biotechnologies, Inc. ($LBIO) and a Vice President, Manufacturing in Lion Biotechnologies, Inc. ($LBIO).
Address: 21900 BURBANK BOULEVARD, 3RD FLOOR WOODLAND HILLS 91367 CA
Companies in which James G. Bender is an Insider
ImmunoCellular Therapeutics, Ltd.
Trading Symbol: IMUCIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James G. Bender: VP Product Development & Mfg., VP, Product Development & Mfg.
Holdings: 879 shares
Current Value: $2,224
Latest Transaction: Jul 31 2012
$IMUC Market Capitalization: $8.58M
$IMUC Previous Close: $2.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IOVANCE BIOTHERAPEUTICS, INC.
Trading Symbol: IOVAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James G. Bender: Vice President - Manufacturing, Vice President, Manufacturing
Holdings: 88,726 shares
Current Value: $629,955
Latest Transaction: Mar 15 2016
$IOVA Market Capitalization: $437.71M
$IOVA Previous Close: $7.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of James G. Bender
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 15 2016 | LBIO | Lion Biotechnologi ... | Bender James G. | Vice President - Ma ... | Option Exercise | A | 5.05 | 30,000 | 151,500 | 30,000 | |
Dec 30 2015 | LBIO | Lion Biotechnologi ... | Bender James G. | Vice President, Man ... | Option Exercise | A | 7.58 | 27,622 | 209,375 | 27,622 | |
Dec 30 2015 | LBIO | Lion Biotechnologi ... | Bender James G. | Vice President, Man ... | Payment of Exercise | F | 5.76 | 11,274 | 64,938 | 88,726 | 100 K to 88.7 K (-11.27 %) |
Dec 09 2014 | LBIO | Lion Biotechnologi ... | Bender James G. | Vice President, Man ... | Option Exercise | A | 6.25 | 46,666 | 291,663 | 46,666 | |
Jan 13 2014 | LBIO | Lion Biotechnologi ... | Bender James G. | Vice President, Man ... | Option Exercise | A | 9.60 | 100,000 | 960,000 | 100,000 | |
Jan 13 2014 | LBIO | Lion Biotechnologi ... | Bender James G. | Vice President, Man ... | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
Jul 31 2012 | IMUC | ImmunoCellular The ... | Bender James G. | VP, Product Develop ... | Option Exercise | A | 3.42 | 75,000 | 256,500 | 75,000 |